Liquidia (NASDAQ:LQDA) Stock: Insider Jason Adair Sells 688 Shares

Liquidia Corporation (NASDAQ:LQDA) insider Jason Adair sold 688 shares of the stock in a transaction dated Monday, October 26th. The stock was sold at an average price of $43.19, for a total transaction of $29,714.72. Following the transaction, the insider owned 177,269 shares in the company, valued at approximately $7,656,248.11. The trade was a 0.39% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Jason Adair also recently made the following trade(s):

• On Monday, October 12th, Jason Adair sold 7,301 shares of Liquidia stock. The shares were sold at an average price of $28.48, for a total transaction of $207,932.48.
• On Friday, August 21st, Jason Adair sold 73,631 shares of Liquidia stock. The shares were sold at an average price of $69.09, for a total transaction of $5,087,165.79.

Liquidia Stock Down 1.6%

Liquidia stock opened at $44.99 on Friday. The business has a fifty day moving average of $53.51 and a two-hundred day moving average of $54.26. The company has a quick ratio of 2.12, a current ratio of 2.31 and a debt-to-equity ratio of 0.63. The firm has a market cap of $4.03 billion, a P/E ratio of 33.37, a P/E/G ratio of 0.40 and a beta of 0.61. Liquidia Corporation has a twelve month low of $22.21 and a twelve month high of $93.61.

Liquidia (NASDAQ:LQDA) last issued its quarterly earnings data on Wednesday, August 12th. The company reported $0.74 earnings per share for the quarter, missing analysts’ consensus estimates of $0.76 by ($0.02). The company had revenue of $171.68 million for the quarter, compared to the consensus estimate of $168.48 million. Liquidia had a net margin of 30.74% and a return on equity of 149.65%. Liquidia’s revenue for the quarter was up 1842.1% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.49) EPS. On average, analysts forecast that Liquidia Corporation will post 2.05 earnings per share for the current fiscal year.

Institutional Trading of Liquidia

Institutional investors and hedge funds have recently bought and sold shares of the business. Bank of America Corp DE lifted its stake in shares of Liquidia by 18.7% in the 1st quarter. Bank of America Corp DE now owns 2,287,792 shares of the company’s stock valued at $86,341,000 after purchasing an additional 360,372 shares during the period. Eversept Partners LP grew its position in Liquidia by 33.0% during the first quarter. Eversept Partners LP now owns 677,392 shares of the company’s stock valued at $25,565,000 after buying an additional 167,949 shares during the period. Pale Fire Capital SE grew its position in Liquidia by 2.4% during the first quarter. Pale Fire Capital SE now owns 388,377 shares of the company’s stock valued at $14,657,000 after buying an additional 8,985 shares during the period. Bank of New York Mellon Corp acquired a new stake in Liquidia during the second quarter valued at $29,694,000. Finally, Seven Fleet Capital Management LP increased its holdings in Liquidia by 25.2% in the second quarter. Seven Fleet Capital Management LP now owns 256,603 shares of the company’s stock valued at $20,459,000 after buying an additional 51,727 shares in the last quarter. 64.54% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms have commented on LQDA. Wells Fargo & Company increased their price target on Liquidia from $30.00 to $33.00 and gave the company an “equal weight” rating in a research note on Wednesday, October 14th. Royal Bank Of Canada set a $65.00 price target on Liquidia in a research note on Thursday, October 15th. BTIG Research upgraded shares of Liquidia from a “neutral” rating to a “buy” rating and set a $70.00 price objective on the stock in a report on Wednesday, October 14th. Weiss Ratings raised shares of Liquidia from a “sell (d-)” rating to a “hold (c)” rating in a research report on Tuesday, September 22nd. Finally, HC Wainwright increased their price objective on shares of Liquidia from $58.00 to $65.00 and gave the company a “buy” rating in a research report on Thursday, October 15th. One analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, four have issued a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, Liquidia currently has an average rating of “Hold” and an average price target of $72.85.

About Liquidia

Liquidia Corporation is a biopharmaceutical company focused on developing and commercializing therapies for patients with pulmonary hypertension and other serious cardiopulmonary diseases. The company is headquartered in Research Triangle Park, North Carolina, and uses its proprietary PRINT technology to engineer drug particles with controlled size, shape and composition for inhaled and injectable medicines.

Liquidia’s lead product is Yutrepia (treprostinil) inhalation powder, a dry-powder formulation of treprostinil delivered through a proprietary inhaler.